CHARACTERIZATION OF PLATELET-ACTIVATING-FACTOR SYNTHESIS IN GLOMERULAR ENDOTHELIAL-CELL LINES

被引:4
|
作者
KESTER, M
NOWINSKI, RJ
HOLTHOFER, H
MARSDEN, PA
DUNN, MJ
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106
[3] UNIV HELSINKI,DEPT BACTERIOL & IMMUNOL,HELSINKI,FINLAND
[4] UNIV HELSINKI,DEPT MED GENET,HELSINKI,FINLAND
[5] UNIV TORONTO,TORONTO,ON,CANADA
[6] ST MICHAELS HOSP,DEPT MED,TORONTO M5B 1W8,ON,CANADA
关键词
D O I
10.1038/ki.1994.412
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Platelet-activating factor synthesis in two transformed lines of glomerular endothelial cells was characterized and contrasted with platelet-activating factor production in macrovascular-derived endothelial cells as well as with glomerular cells of mesenchymal origin. Platelet-activating factor synthesis was assessed in intact cells and in cell-free preparations. Glomerular endothelial cells constitutively synthesize bio-active alkyl-PAF, and this basal activity can be chronically augmented by various inflammatory and thrombotic agents. In contrast, thrombin-mediated platelet-activating factor formation in bovine pulmonary aortic endothelial cells as well as in glomerular mesangial cells is acute and transient. The potential role of anti-inflammatory prostanoids to function as negative feedback modulators of thrombin- or endothelin-mediated platelet-activating factor synthesis was also investigated, as the synthesis of platelet-activating factor is often associated with the formation of these prostanoids. Indomethacin augmented receptor-mediated platelet-activating factor synthesis while prostanoids of the E and I series reduced agonist-stimulated PAF synthesis. In summary, the unique capacity of glomerular endothelial cells to respond to inflammatory stimuli with sustained platelet-activating factor synthesis is a clear indication of this cell's pivotal role in augmenting the inflammatory response in the limited environment of the glomerulus.
引用
收藏
页码:1404 / 1412
页数:9
相关论文
共 50 条
  • [41] PRIOR EXPOSURE TO ANTITHROMBIN III PREVENTS THROMBIN-INDUCED ENDOTHELIAL-CELL PLATELET-ACTIVATING-FACTOR PRODUCTION AND INHIBITS THROMBIN-ENHANCED NEUTROPHIL-MEDIATED ENDOTHELIAL-CELL DAMAGE
    WICKHAM, NWR
    VERCELLOTTI, GM
    YIN, HQ
    GUSTAFSON, KS
    MOLDOW, CF
    JACOB, HS
    CLINICAL RESEARCH, 1987, 35 (06): : A851 - A851
  • [42] SYNTHESIS OF PLATELET-ACTIVATING-FACTOR BY NEONATAL LAMB LUNGS
    IBE, BO
    ISENBERG, WB
    RAJ, JU
    FASEB JOURNAL, 1991, 5 (05): : A1432 - A1432
  • [43] THE SYNTHESIS OF PLATELET-ACTIVATING-FACTOR IN BRAIN AND NEURAL CELLS
    GORACCI, G
    FRANCESCANGELI, E
    DREYFUS, H
    BOILA, A
    FREYSZ, L
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 10 (1-2): : 7 - 8
  • [44] PLATELET-ACTIVATING-FACTOR AND ASTHMA
    BARNES, PJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 629 : 193 - 204
  • [45] PHARMACOLOGY OF PLATELET-ACTIVATING-FACTOR
    BRAQUET, P
    VARGAFTIG, BB
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (05) : 10 - 19
  • [46] PLATELET-ACTIVATING-FACTOR AND THE CIRCULATION
    VANDONGEN, R
    JOURNAL OF HYPERTENSION, 1991, 9 (09) : 771 - 778
  • [47] PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    KOLTAI, M
    BRAQUET, PG
    CLINICAL REVIEWS IN ALLERGY, 1994, 12 (04): : 361 - 380
  • [48] PLATELET-ACTIVATING-FACTOR AND ASTHMA
    MORLEY, J
    AGENTS AND ACTIONS, 1986, 19 (1-2): : 100 - 108
  • [49] ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR
    TOKUMURA, A
    TSUKATANI, H
    SEIKAGAKU, 1985, 57 (12): : 1618 - 1623
  • [50] PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    SAUNDERS, RN
    HANDLEY, DA
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1987, 27 : 237 - 255